ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $128,815 | +21.2% | 26,076 | +54.3% | 0.16% | +51.9% |
| Q4 2022 | $106,307 | -45.8% | 16,901 | -13.5% | 0.10% | -46.7% |
| Q3 2022 | $196,000 | +9.5% | 19,539 | +24.5% | 0.20% | +18.2% |
| Q2 2022 | $179,000 | -83.0% | 15,700 | -62.4% | 0.16% | -36.3% |
| Q4 2020 | $1,055,000 | -78.0% | 41,800 | -67.1% | 0.26% | -81.8% |
| Q3 2020 | $4,797,000 | +201.1% | 127,196 | +242.0% | 1.42% | +167.3% |
| Q2 2020 | $1,593,000 | +4.3% | 37,196 | -52.6% | 0.53% | -17.0% |
| Q1 2020 | $1,527,000 | -22.1% | 78,532 | +4.1% | 0.64% | -7.1% |
| Q4 2019 | $1,959,000 | -4.7% | 75,418 | 0.0% | 0.69% | -11.9% |
| Q3 2019 | $2,055,000 | +19.4% | 75,418 | +16.6% | 0.78% | +24.1% |
| Q2 2019 | $1,721,000 | – | 64,662 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |